LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.

Xu T, Liu CL, Li T, Zhang YH, Zhao YH

Open source

DOI
10.26355/eurrev_201906_18062
Published
2019 Jun
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201906_18062,
  title = {LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.},
  author = {Xu T and Liu CL and Li T and Zhang YH and Zhao YH},
  year = {2019},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201906_18062},
  url = {https://doi.org/10.26355/eurrev_201906_18062}
}

RIS

TY  - JOUR
TI  - LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.
AU  - Xu T
AU  - Liu CL
AU  - Li T
AU  - Zhang YH
AU  - Zhao YH
PY  - 2019
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201906_18062
UR  - https://doi.org/10.26355/eurrev_201906_18062
ER  - 

APA

T, X., CL, L., T, L., YH, Z., & YH, Z. (2019). LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201906_18062

Source records